Stimcell Energetics, Inc. Stimcell Energetics, Inc.

Stimcell Energetics, Inc.

STME

Rank in Stocks #29903
StimCell Energetics Inc. is a biotechnology company focused on the research,... StimCell Energetics Inc. is a biotechnology company focused on the research, development, and market introduction of both therapeutic and non-therapeutic solutions. These products are intended to benefit individuals in the United States who are managing conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and issues with kidney function. The company's primary product line is the eBalance system, which comprises two versions: the eBalance Pro System, designed for clinical application by healthcare practitioners, and the eBalance Home System, created for personal use to promote overall well-being and alleviate pain. Both systems are operated via the eBalance Console, a central control unit that offers three distinct pre-programmed microcurrent algorithms: one for general wellness, another for pain relief, and a 'dual' mode that combines both. Additionally, these eBalance products aim to provide temporary relief for discomfort in various body parts, including the shoulders, waist, back, neck, arms, and legs. Established in 2010, the company initially operated under the name Cell MedX Corp. before officially rebranding as StimCell Energetics Inc. in November 2024. Its corporate headquarters are located in Vancouver, Canada.
Share Price
$0.3
Last synced: 2026-11-10
Market Cap
$6.34M
Change (1 day)
36.36%
Change (1 year)
-37.50%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Stimcell Energetics, Inc. (STME)

Category

Healthcare
EPS for Stimcell Energetics, Inc. (STME)
EPS as of August 2026 TTM: $-0.03
According to Stimcell Energetics, Inc.'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.03, a decrease compared to its 2024 EPS of 0.00.
EPS history for Stimcell Energetics, Inc. from 2011 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.03 10.67%
2025 $-0.03 782.35%
2024 0.00 -56.96%
2023 $-0.01 -28.83%
2022 $-0.01 -28.39%
2021 $-0.02 -25.48%
2020 $-0.02 1.96%
2019 $-0.02 -44.26%
2018 $-0.04 7.96%
2017 $-0.03 -50.87%
2016 $-0.07 107.21%
2015 $-0.03 5,450.00%
2014 0.00 50.00%
2013 0.00 -20.00%
2012 0.00 0.00%
2011 0.00 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$2.70 -8,232.53%
US
$4.09 -12,419.28%
IE
$9.45 -28,563.86%
US
$2.37 -7,238.55%
US
$1.77 -5,431.33%
US

Questions about Stimcell Energetics, Inc.'s earnings per share (EPS)

What is Stimcell Energetics, Inc.'s earnings per share (EPS)?

Stimcell Energetics, Inc.'s earnings per share (EPS) over the last twelve months is $-0.03, as of Aug 2026.

What was Stimcell Energetics, Inc.'s earnings per share (EPS) in 2025?

In 2025, Stimcell Energetics, Inc.'s earnings per share (EPS) was $-0.03, compared with 0.00 in 2024.

How has Stimcell Energetics, Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Stimcell Energetics, Inc.'s earnings per share (EPS) was highest in 2024 (0.00) and lowest in 2025 ($-0.03).

How does Stimcell Energetics, Inc.'s earnings per share (EPS) compare with similar companies?

Stimcell Energetics, Inc.'s earnings per share (EPS) ($-0.03) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.